Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin with or without 3BNC117 for HIV-1 reservoir
NCT02850016Phase 2Completed
- Sponsor
- The Rockefeller University
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Anti-infectious Disease mAbs
- Countries
- 3
01
Overview
A Phase 2 trial of Teropavimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by The Rockefeller University. Started Jan 2017; status: completed.
02
Drugs
Teropavimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02850016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850016.